Article contents
A novel treatment for patients with hereditary haemorrhagic telangiectasia
Published online by Cambridge University Press: 08 March 2006
Abstract
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by dermal, mucosal, and visceral telangiectases as well as pulmonary and cerebral arteriovenous malformations. Recurrent epistaxis occurs in the majority of patients, and by the very nature of the thin walled vessels involved it is often refractory to conventional forms of treatment. We present the case of an 82-year-old lady with intractable epistaxis secondary to HHT, that was successfully controlled by the application of fibrin glue.
- Type
- Research Article
- Information
- Copyright
- © Royal Society of Medicine Press Limited 2002
- 3
- Cited by